Search for: "Insys"
Results 61 - 80
of 121
Sort by Relevance
|
Sort by Date
5 Mar 2019, 6:55 am
There, a judge let in some pretty salacious testimony in the big Insys trial:It’s an old marketing adage: Sex sells. [read post]
20 Feb 2019, 8:07 am
Namaste Technologies (NASDAQOTH:NXTTF): down 75.2% Wayland Group: down 67.6% Insys Therapeutics(NASDAQ:INSY): down 63.6% Aphria(NYSE:APHA): down 61.3% Radient Technologies: down 60.7% Liberty Health Sciences: down 58% VIVO Cannabis: down 57.7% Emerald Health Therapeutics: down 51.5% Auxly Cannabis Group(NASDAQOTH:CBWTF): down 51.5% Medical Marijuana, Inc. [read post]
7 Feb 2019, 5:05 am
The federal government uses the Racketeer Influenced and Corrupt Organizations Act (RICO), approved in 1970, to go after Insys executives, claiming they engaged in a racketeering conspiracy scheme to realize revenues from Subsys sales. [read post]
30 Jan 2019, 1:49 pm
Two additional former Insys executives—former Insys CEO and President Michael Babich and former Vice President of Sales Alec Burlakoff—were also charged in the case but have pleaded guilty and are cooperating with prosecutors. [read post]
28 Jan 2019, 10:33 am
The trial - of Insys founder John Kapoor and four other defendants - had been scheduled to start Monday morning. [read post]
16 Jan 2019, 5:59 am
Michael Babich, the former Insys CEO who resigned in 2015, admitted to conspiracy and mail fraud charges after entering into a cooperation deal with prosecutors. [read post]
13 Jan 2019, 9:02 pm
Patent and Trademark Office Patent Trial and Appeal Board (PTAB) issued a Final Written Decision in Insys Development Co., Inc. v. [read post]
10 Jan 2019, 6:39 am
The post Former Insys CEO pleads guilty to conspiracy appeared first on JURIST - News - Legal News & Commentary. [read post]
7 Dec 2018, 6:20 am
Insys and Top Executives Face Crime Allegations Amid Bankruptcy [read post]
20 Nov 2018, 5:23 am
” The amended lawsuit also add Insys Therapeutics, Inc., alleging that the company provided kickbacks to doctors to incentivize them to write prescriptions for opioids. [read post]
5 Nov 2018, 3:08 pm
In New York, criminal charges were filed against five other doctors earlier this year for taking kickbacks and bribes from Insys, the manufacturer of a nasal spray with fentanyl. [read post]
17 Sep 2018, 6:55 am
” Fierce Pharma reports the Justice Department had alleged that Insys aggressively promoted Subsys for off-label uses. [read post]
6 Sep 2018, 2:10 pm
Maryland authorities announced charges Thursday against an Arizona-based drugmaker that they say engaged in a nationwide scheme "characterized by extraordinary misconduct" to boost profits amid the coast-to-coast opioid epidemic. [read post]
9 Aug 2018, 10:20 am
Insys Therapeutics announced that it had reached a deal to pay at least $150 million to resolve a federal investigation into allegations that it illegally paid kickbacks to doctors to prescribe Subsys, a powerful opioid containing fentanyl. [read post]
25 May 2018, 11:43 am
Insys founder John Kapoor was charged last year with conspiracy, racketeering, fraud and bribery for his role in the scam. [read post]
18 May 2018, 3:08 pm
The United States has separately pursued a number of criminal cases against Insys employees and Subsys prescribers.The cases allege illegal marketing tactics related to Subsys, a sublingual spray form of fentanyl, an opioid painkiller. [read post]
18 May 2018, 3:08 pm
The United States has separately pursued a number of criminal cases against Insys employees and Subsys prescribers.The cases allege illegal marketing tactics related to Subsys, a sublingual spray form of fentanyl, an opioid painkiller. [read post]
18 May 2018, 7:15 am
Continue reading The post Federal Government Joins Whistleblower Suit Against Insys Therapeutics appeared first on Healthcare Fraud Lawyer Blog. [read post]
16 May 2018, 6:23 am
According to the complaint, Insys has caused federal healthcare programs to pay for Subsys for uses... [read post]
15 May 2018, 12:54 pm
According to DOJ’s press release: On April 13, 2018, the United States intervened in five lawsuits accusing Insys Therapeutics Inc., of violating the False Claims Act in connection with the marketing of Subsys, an opioid painkiller manufactured and sold by Insys, the Department of Justice announced today. [read post]
